Return to search results
Lacosamide oral solution
Lacosamide Oral Solution is a prescription drug used to reduce disorganized electrical activity in the brain, commonly for treating seizures. It contains 10 mg/mL of lacosamide and comes in 200 mL or 465 mL bottles. Manufactured by Ascend Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Lacosamide Oral Solution is a prescription drug used to reduce disorganized electrical activity in the brain, commonly for treating seizures. It contains 10 mg/mL of lacosamide and comes in 200 mL or 465 mL bottles. Manufactured by Ascend Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Lacosamide oral solution", "mediaType": "text/html", "description": " Access the FDA dataset for Lacosamide oral solution — ANDA 214672 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214672" } ] |
| identifier | ANDA214672 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-manufacturers", "fda", "health-care", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Lacosamide oral solution |
